Income (Loss) from Continuing Operations [Abstract] | |
NET INCOME | -381M |
Adjustments to Reconcile Income (Loss) to Net Cash Provided by (Used in) Continuing Operations [Abstract] | |
Provision for depreciation | |
Amortization of regulatory assets | |
Deferral of new regulatory assets | |
Nuclear fuel and lease amortization | |
Deferred purchased power and other costs | |
Deferred income taxes and investment tax credits, net | 318M |
Investment impairment | |
Deferred rents and lease market valuation liability | |
Stock-based compensation | |
Accrued compensation and retirement benefits | 2M |
Gain on asset sales | |
Electric service prepayment programs | |
Cash collateral received (paid) | |
(Increase) Decrease in Operating Capital [Abstract] | |
Receivables | -34M |
Materials and supplies | 45M |
Prepaid taxes | |
Accounts payable | -17M |
Accrued taxes | -81M |
Accrued interest | 36M |
Other | |
Net cash provided from operating activities | 2.58B |
New Financing | |
Long-term debt | 521M |
Short-term borrowings, net | 1.28B |
Redemptions and Repayments | |
Long-term debt | -1.02B |
Net controlled disbursement activity | |
Common stock dividend payments | -458M |
Other | -5M |
Net cash provided from financing activities | 316M |
Net Cash Provided by (Used in) Investing Activities [Abstract] | |
Property additions | -2.16B |
Proceeds from asset sales | |
Sales of investment securities held in trusts | 1.36B |
Purchases of investment securities held in trusts | -1.44B |
Cash investments | |
Other | 52M |
Net cash used for investing activities | -2.48B |
Cash and Cash Equivalents, Period Increase (Decrease) [Abstract] | |
Net change in cash and cash equivalents | |
Cash and cash equivalents at beginning of period | 131M |
Cash and cash equivalents at end of period | 551M |